FDA Approved: OXLUMO — Supplemental Application (Alnylam Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OXLUMO (lumasiran) submitted by Alnylam Pharmaceuticals, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• Oxlumo (lumasiran)

Snippet

SUPPL AP for OXLUMO (LUMASIRAN)